Article ; Online: Nanotechnology-based antiviral therapeutics.
Drug delivery and translational research
2020 Volume 11, Issue 3, Page(s) 748–787
Abstract: The host immune system is highly compromised in case of viral infections and relapses are very common. The capacity of the virus to destroy the host cell by liberating its own DNA or RNA and replicating inside the host cell poses challenges in the ... ...
| Abstract | The host immune system is highly compromised in case of viral infections and relapses are very common. The capacity of the virus to destroy the host cell by liberating its own DNA or RNA and replicating inside the host cell poses challenges in the development of antiviral therapeutics. In recent years, many new technologies have been explored for diagnosis, prevention, and treatment of viral infections. Nanotechnology has emerged as one of the most promising technologies on account of its ability to deal with viral diseases in an effective manner, addressing the limitations of traditional antiviral medicines. It has not only helped us to overcome problems related to solubility and toxicity of drugs, but also imparted unique properties to drugs, which in turn has increased their potency and selectivity toward viral cells against the host cells. The initial part of the paper focuses on some important proteins of influenza, Ebola, HIV, herpes, Zika, dengue, and corona virus and those of the host cells important for their entry and replication into the host cells. This is followed by different types of nanomaterials which have served as delivery vehicles for the antiviral drugs. It includes various lipid-based, polymer-based, lipid-polymer hybrid-based, carbon-based, inorganic metal-based, surface-modified, and stimuli-sensitive nanomaterials and their application in antiviral therapeutics. The authors also highlight newer promising treatment approaches like nanotraps, nanorobots, nanobubbles, nanofibers, nanodiamonds, nanovaccines, and mathematical modeling for the future. The paper has been updated with the recent developments in nanotechnology-based approaches in view of the ongoing pandemic of COVID-19.Graphical abstract. |
|---|---|
| MeSH term(s) | Antiviral Agents/administration & dosage ; Antiviral Agents/chemistry ; COVID-19 Vaccines/administration & dosage ; Drug Carriers ; Drug Compounding ; Humans ; Nanomedicine ; Nanoparticles ; Polymers/chemistry ; Vaccination ; Viral Vaccines/administration & dosage ; Viral Vaccines/chemistry ; Virus Diseases/immunology ; Virus Diseases/prevention & control ; Virus Diseases/virology |
| Chemical Substances | Antiviral Agents ; COVID-19 Vaccines ; Drug Carriers ; Polymers ; Viral Vaccines |
| Keywords | covid19 |
| Language | English |
| Publishing date | 2020-12-21 |
| Publishing country | United States |
| Document type | Journal Article ; Review |
| ZDB-ID | 2590155-2 |
| ISSN | 2190-3948 ; 2190-393X |
| ISSN (online) | 2190-3948 |
| ISSN | 2190-393X |
| DOI | 10.1007/s13346-020-00818-0 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.